Daiwa Securities Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-390
Closed -$40K 1280
2025
Q4
$40K Sell
390
-18
-4% -$1.61K ﹤0.01% 1131
2025
Q3
$25K Hold
408
﹤0.01% 1130
2025
Q2
$21K Hold
408
﹤0.01% 1097
2025
Q1
$17K Hold
408
﹤0.01% 1074
2024
Q4
$12K Sell
408
-60
-13% -$1.69K ﹤0.01% 1108
2024
Q3
$11K Buy
468
+56
+14% +$1.58K ﹤0.01% 1124
2024
Q2
$12K Hold
412
﹤0.01% 1155
2024
Q1
$8K Hold
412
﹤0.01% 1176
2023
Q4
$11K Hold
412
﹤0.01% 1164
2023
Q3
$12K Hold
412
﹤0.01% 1118
2023
Q2
$15K Hold
412
﹤0.01% 1121
2023
Q1
$10K Hold
412
﹤0.01% 1111
2022
Q4
$11K Buy
412
+32
+8% +$1.46K ﹤0.01% 1109
2022
Q3
$20K Hold
380
﹤0.01% 1096
2022
Q2
$15K Buy
380
+83
+28% +$4.11K ﹤0.01% 1123
2022
Q1
$20K Hold
297
﹤0.01% 1110
2021
Q4
$30K Sell
297
-50
-14% -$5.17K ﹤0.01% 1102
2021
Q3
$43K Buy
347
+148
+74% +$17.6K ﹤0.01% 1065
2021
Q2
$25K Sell
199
-1,919
-91% -$258K ﹤0.01% 1011
2021
Q1
$323K Buy
2,118
+1,930
+1,027% +$292K ﹤0.01% 883
2020
Q4
$24K Sell
188
-351
-65% -$40.4K ﹤0.01% 966
2020
Q3
$60K Buy
539
+9
+2% +$823 ﹤0.01% 930
2020
Q2
$37K Hold
530
﹤0.01% 923
2020
Q1
$37K Hold
530
﹤0.01% 973
2019
Q4
$41K Buy
+530
New +$38.2K ﹤0.01% 972

Other funds holding GH

Daiwa Securities Group's GH Position: Q1 2026 in Review

Daiwa Securities Group sold out of Guardant Health (GH) in Q1 2026, closing a stake of 390 shares — an estimated $40K sold.

Daiwa Securities Group first reported a position in GH in Q4 2019 and held it in 25 quarters. The position peaked at $323K in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Daiwa Securities Group reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 390 Guardant Health shares in Q1 2026, an estimated $40K.
  • Daiwa Securities Group first reported a position in Guardant Health in Q4 2019 and held it in 25 quarters.
  • Daiwa Securities Group's Guardant Health position peaked at $323K in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.